Lord, Abbett & Co »

Bridgebio Pharma shares owned by Lord, Abbett & Co

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Lord, Abbett & Co from 13F filings

Historical chart of Lord, Abbett & Co investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Lord, Abbett & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Lord, Abbett & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $7.1M 8.4M 0.85

More positions owned by Lord, Abbett & Co

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
JPMorgan Chase & Co. (JPM)
Apple (AAPL)
UnitedHealth (UNH)
Parker-Hannifin Corporation (PH)
Comcast Corporation (CMCSA)
Amazon (AMZN)
Abbvie (ABBV)
Charles Schwab Corporation (SCHW)
Eli Lilly & Co. (LLY)
Morgan Stanley (MS)
Alphabet Inc Class A cs (GOOGL)
Arista Networks (ANET)
Exxon Mobil Corporation (XOM)

View all positions for Lord, Abbett & Co

Top funds holding Bridgebio Pharma

Braidwell
Ubs Global Asset Management Americas
D. E. Shaw & Co
Weiss Asset Management LP[1
Aristeia Capital
Context Capital Management
Laurion Capital Management
Point72 Asset Management
DeepCurrents Investment Group
Diameter Capital Partners
Wells Fargo & Company
Aequim Alternative Investments
Segantii Capital Management
Calamos Advisors
Lord, Abbett & Co

View all funds holding Bridgebio Pharma